🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, claiming the companies withheld safety concerns that the drug presented to pediatric neurological development.

This legal action follows thirty days after Former President Trump promoted an unsubstantiated connection between consuming Tylenol - referred to as paracetamol - throughout gestation and autism in young ones.

The attorney general is filing suit against J&J, which previously sold the medication, the only pain reliever suggested for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he said they "deceived the public by gaining financially from suffering and pushing pills ignoring the potential hazards."

The manufacturer says there is insufficient reliable data linking Tylenol to autism.

"These companies misled for generations, deliberately risking numerous people to boost earnings," Paxton, from the Republican party, stated.

The company commented that it was "seriously troubled by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, the company also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that shows a verified association between using paracetamol and autism."

Organizations acting on behalf of doctors and healthcare providers share this view.

ACOG has said acetaminophen - the main ingredient in Tylenol - is among limited choices for expectant mothers to treat discomfort and fever, which can pose major wellness concerns if ignored.

"In over twenty years of research on the utilization of acetaminophen in pregnancy, no reliable research has definitively established that the consumption of paracetamol in any period of gestation results in neurodevelopmental disorders in young ones," the group stated.

This legal action cites recent announcements from the Trump administration in arguing the drug is reportedly hazardous.

Last month, Trump generated worry from health experts when he told expectant mothers to "fight like hell" not to consume acetaminophen when unwell.

The FDA then released a statement that medical professionals should consider limiting the usage of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had pledged in spring to conduct "comprehensive study program" that would establish the origin of autism spectrum disorder in a limited time.

But authorities cautioned that discovering a single cause of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism is a form of enduring cognitive variation and condition that affects how persons encounter and engage with the world, and is diagnosed using doctors' observations.

In his court filing, Paxton - who supports Trump who is running for US Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the firms "destroy any marketing or advertising" that asserts Tylenol is safe for pregnant women.

The Texas lawsuit mirrors the concerns of a group of guardians of children with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

A federal judge threw out the legal action, saying studies from the family's specialists was lacking definitive proof.